{"id":6132,"date":"2023-08-03T14:06:23","date_gmt":"2023-08-03T14:06:23","guid":{"rendered":"https:\/\/splmed.com\/?p=6132"},"modified":"2023-11-07T15:36:43","modified_gmt":"2023-11-07T15:36:43","slug":"spl-medical-announces-achievement-of-next-major-clinical-development-milestone-for-its-breakthrough-platform-product-ferrotran-now-75-patients-included-in-phase-iii-trial","status":"publish","type":"post","link":"https:\/\/splmed.com\/english\/spl-medical-announces-achievement-of-next-major-clinical-development-milestone-for-its-breakthrough-platform-product-ferrotran-now-75-patients-included-in-phase-iii-trial\/","title":{"rendered":"SPL Medical announces achievement of next major clinical development milestone for its breakthrough platform product Ferrotran\u00ae: Now >75% patients included in Phase III trial"},"content":{"rendered":"<p class=\"p2\">SPL medical has its proprietary iron-based nano-particle Ferrotran<span class=\"s2\">\u00ae <\/span>(Ferumoxtran) product and platform in clinical Phase III. The pivotal trial named PROSTAPROGRESS has now reached the next major milestone by inclusion of over 75% of the patients into this trial.<\/p>","protected":false},"excerpt":{"rendered":"<p>SPL medical has its proprietary iron-based nano-particle Ferrotran\u00ae (Ferumoxtran) product and platform in clinical Phase III. The pivotal trial named PROSTAPROGRESS has now reached the next major milestone by inclusion of over 75% of the patients into this trial.<\/p>","protected":false},"author":2,"featured_media":5922,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[],"class_list":["post-6132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release"],"_links":{"self":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts\/6132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/comments?post=6132"}],"version-history":[{"count":5,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts\/6132\/revisions"}],"predecessor-version":[{"id":6138,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts\/6132\/revisions\/6138"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/media\/5922"}],"wp:attachment":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/media?parent=6132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/categories?post=6132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/tags?post=6132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}